Australia's palliative care market is projected to grow from $156.96 Mn in 2022 to $324.42 Mn by 2030, registering a CAGR of 9.5% during the forecast period of 2022–30. The main factors driving the growth would be as increasing prevalence of chronic diseases, the growing aging population, advancements in technology, and government support. The market is segmented by service type and by the end user. Some of the major players include Hammond Care, Japara Healthcare, Aveo Group, Brightwater Care Group, and Home Instead.
Australia's palliative care market is projected to grow from $156.96 Mn in 2022 to $324.42 Mn by 2030, registering a CAGR of 9.5% during the forecast period of 2022 - 2030. In Australia, the healthcare spending for 2019–20 was $202.5 Bn, or $7,926 per person. Compared to the 3.4% decade average, the actual increase in healthcare spending was 1.8%, which was lower. In Australia, the government provides the majority of the funding for healthcare, although patients also contribute a sizable portion of the costs.
Palliative care is an approach that aids patients and their families to live better while they are battling terminal illnesses. Palliative care services prevent and lessen suffering through the early detection, correct assessment, and treatment of pain and other diseases, including those that are physical, mental, or spiritual. Palliative care also aids patients and their carers by taking a collaborative stance. This means providing a support system and catering to practical requirements in order to help people live as actively as possible until death. Palliative care is essential for a variety of illnesses, including cancer, chronic respiratory conditions, diabetes, kidney failure, chronic liver disease, and others.
Market Growth Drivers
The Australian palliative care market is expected to be driven by factors such as the increasing prevalence of chronic diseases, the growing aging population, advancements in technology, and government support. The Australian government has made steps to expand access to palliative care services, including boosting financing for these programs and the number of hospice and palliative care facilities across the nation.
Market Restraints
The cost of palliative care services is high and the lack of adequate infrastructure limits the growth of the palliative care market in the country. Further, Palliative care services are frequently dispersed, which can hinder market expansion, lead to poor care coordination, and result in less-than-ideal outcomes for patients.
Key Players
the Australian Department of Health is the primary organization in charge of creating and carrying out healthcare policies, particularly those concerning palliative care. To guarantee that patients receive kind and efficient care at the end of their life, the department has created rules and criteria for the delivery of palliative care services. The Australian Health Practitioner Regulation Agency (AHPRA), which is in charge of the registration and accreditation of healthcare providers, is in charge of the regulatory framework for palliative care services. In addition to informing patients and their families about the quality of palliative care services, the organization makes sure that palliative care practitioners adhere to the specified standards and rules.
In Australia, Medicare, the nation's public health insurance program, is predominantly used to pay for palliative care services. All qualified Australian citizens and permanent residents have access to a wide range of medical services through the Medicare system, including palliative care services. The Medicare Benefits Schedule (MBS), a list of medical services that are covered by the Medicare system, is where patients who need palliative care services can apply for reimbursement. A variety of palliative care services, such as inpatient and outpatient care, home-based care, and support services for patients and their families, are covered by the MBS. The Australian government's Pharmaceutical Benefits Scheme (PBS), which helps to pay the cost of prescription prescriptions for individuals who are qualified, is another source of financial assistance for some patients in addition to Medicare.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Service Type (Revenue, USD Billion):
Based on service type, the Australia palliative care market is divided into the following:
By End User (Revenue, USD Billion):
Based on end-user type, the Australia palliative care market is divided into the following:
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.